Atossa Therapeutics
ATOS
#10646
Rank
NZ$42.4 M
Marketcap
NZ$4.25
Share price
-1.93%
Change (1 day)
227.92%
Change (1 year)

Market capitalization of Atossa Therapeutics (ATOS)

Market cap: NZ$42.4 Million

As of August 2026 Atossa Therapeutics has a market cap of NZ$42.4 Million. This makes Atossa Therapeutics the world's 10646th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Atossa Therapeutics from 2012 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$42.4 M-71.15%
2025NZ$0.14 B-32.85%
2024NZ$0.21 B25.51%
2023NZ$0.17 B65.42%
2022NZ$0.10 B-64.46%
2021NZ$0.29 B373.79%
2020NZ$62.6 M194.11%
2019NZ$21.28 M139.42%
2018NZ$8.89 M-24.56%
2017NZ$11.78 M52.84%
2016NZ$7.71 M-49.5%
2015NZ$15.26 M-65.94%
2014NZ$44.83 M-14.51%
2013NZ$52.43 M-14.38%
2012NZ$61.24 M

End of Day market cap according to different sources

On Aug 23rd, 2026 the market cap of Atossa Therapeutics was reported to be:

NZ$42.4 Million
by Nasdaq info icon info icon
NZ$42.4 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
NZ$1.089 T 2,569,199.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
NZ$45.12 B 106,317.73%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
NZ$45.62 B 107,513.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Translate Bio
TBIO.defunct
NZ$4.72 B 11,040.86%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
NZ$3.69 B 8,622.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
NZ$61.2 M 44.35%๐Ÿ‡บ๐Ÿ‡ธ USA